Mihailo V Rebec

Dr. Rebec has been intimately involved in the development of pioneering sensor technology used in the WaveForm CGM, dating back to 2004. He is an author on 30+ patents covering instrumentation, algorithm development, and innovative analysis methods. Dr. Rebec continues to lead the technical, clinical, and regulatory efforts for the WaveForm CGM in the EU, US, and China, including directing WaveForm’s CGM sensor research and development work.

Prior to WaveForm’s acquisition of the technology in 2016, Dr. Rebec served as the lead research scientist in the advanced technology group of the Bayer Diabetes Group. He was involved in extensive research in the areas of noninvasive and minimally invasive glucose analysis.